Source: Eur Respir J 2014; 44: 1069-1072



Rating:

Share or cite this content

Citations should be made in the following way:
Laveneziana Pierantonio, Montani David, Dorfmüller Peter, Girerd Barbara, Sitbon Olivier, Jaïs Xavier, Savale Laurent, Eyries Mélanie, Soubrier Florent, Similowski Thomas, Simonneau Gérald, Humbert Marc, Garcia Gilles. Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations. Eur Respir J 2014; 44: 1069-1072

Member's Comments

No comment yet.

Related content which might interest you: Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema Source: Eur Respir J, 55 (1) 1901319; 10.1183/13993003.01319-2019 Year: 2020 Mechanisms and consequences of exertional dyspnoea in combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019 Acidotic responses in patients with idiopathic pulmonary fibrosis: The mechanisms of exertional dyspnea Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Common mechanisms of exertional dyspnoea in chronic lung disorders Source: International Congress 2018 – Dyspnoea: a multidimensional and multidisciplinary approach Year: 2018 Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis Source: Eur Respir J 2009; 33: 517-520 Year: 2009 Exertional dyspnoea in pulmonary arterial hypertension Source: Eur Respir Rev, 26 (145) 170039; 10.1183/16000617.0039-2017 Year: 2017 Neurophysiological mechanisms of exertional dyspnoea in fibrotic interstitial lung disease Source: Eur Respir J, 51 (1) 1701726; 10.1183/13993003.01726-2017 Year: 2018 Respiratory muscle perfusion limitations and dyspnoea during cycling in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment Year: 2020 Creatinine-height index, pulmonary function and dyspnoa in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017 Impact of anemia on dyspnea on exertion and exercise tolerance in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Exercise assessment in different diseases Year: 2011 Limitation to muscular activity in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 6-7 Year: 2004 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Factors effecting shortness of breath in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Optimising the care and management of patients with COPD Year: 2010 Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history Source: Eur Respir Rev 2009; 18: 170-173 Year: 2009 Programme PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease Source: International Congress 2016 – PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease Year: 2016 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Muscle wasting and dynamic hyperinflation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 277s Year: 2007 Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy Year: 2016